XML 23 R15.htm IDEA: XBRL DOCUMENT
v3.26.1

Accrued Expenses and Other Current Liabilities | 6 Months Ended
--- | ---
Jun. 30, 2026
Payables and Accruals [Abstract] |
Accrued Expenses and Other Current Liabilities | 5. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands):
|  | June 30, 2026 |  |  | December 31, 2025 |
Clinical and development costs |  | $ | 437 |  |  | $ | 246 |
Manufacturing and quality costs |  |  | 121 |  |  |  | 145 |
Payroll and employee-related costs |  |  | 2,229 |  |  |  | 2,685 |
Facility and other |  |  | 952 |  |  |  | 896 |
|  | $ | 3,739 |  |  | $ | 3,972 |

X
- Definition The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 720 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1 + Details
Name: | us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration